GOSR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.600800E-01
Normal-vs-Stage2
9.266200E-01
Normal-vs-Stage3
1.587840E-01
Normal-vs-Stage4
2.020200E-01
Stage1-vs-Stage2
1.125210E-01
Stage1-vs-Stage3
2.020400E-02
Stage1-vs-Stage4
8.558000E-01
Stage2-vs-Stage3
1.159190E-01
Stage2-vs-Stage4
1.312390E-01
Stage3-vs-Stage4
1.756430E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.309000E-01
Normal-vs-AfricanAmerican
3.198000E-01
Normal-vs-Asian
6.921800E-01
Caucasian-vs-AfricanAmerican
3.118600E-01
Caucasian-vs-Asian
3.177000E-01
AfricanAmerican-vs-Asian
7.403700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.195800E-01
Normal-vs-Female
7.104200E-01
Male-vs-Female
2.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.603800E-01
Normal-vs-Age(41-60Yrs)
4.928600E-01
Normal-vs-Age(61-80Yrs)
9.638200E-01
Normal-vs-Age(81-100Yrs)
7.297800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.466800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.974800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.610780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.696100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.541920E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.630000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.573400E-01
Normal-vs-Daily Drinker
6.698600E-01
Normal-vs-Weekly Drinker
9.321600E-01
Normal-vs-Occasional Drinker
3.690400E-01
Normal-vs-Social Drinker
4.862000E-01
Non Drinker-vs-Daily Drinker
4.666600E-01
Non Drinker-vs-Weekly Drinker
2.024600E-01
Non Drinker-vs-Occasional Drinker
2.738600E-03
Non Drinker-vs-Social Drinker
3.496300E-02
Daily Drinker-vs-Weekly Drinker
5.813600E-01
Daily Drinker-vs-Occasional Drinker
9.899300E-03
Daily Drinker-vs-Social Drinker
6.684400E-02
Weekly Drinker-vs-Occasional Drinker
8.012000E-02
Weekly Drinker-vs-Social Drinker
1.354370E-01
Occasional Drinker-vs-Social Drinker
7.603600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.205610E-01
Normal-vs-Grade 2
9.876500E-03
Normal-vs-Grade 3
2.980200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.960420E-01
Grade 1-vs-Grade 3
4.569600E-01
Grade 1-vs-Grade 4
1.205610E-01
Grade 2-vs-Grade 3
2.178800E-01
Grade 2-vs-Grade 4
9.876500E-03
Grade 3-vs-Grade 4
2.980200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.282200E-01
Normal-vs-NonDiabetic
8.276400E-01
Diabetic-vs-NonDiabetic
6.900000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.948400E-01
Normal-vs-NoPancreatitis
9.245000E-01
Pancreatitis-vs-NoPancreatitis
6.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.025800E-01
Normal-vs-N1
9.243400E-01
N0-vs-N1
2.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.771200E-01
Normal-vs-TP53-NonMutant
6.206800E-01
TP53-Mutant-vs-TP53-NonMutant
6.666400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
